South Korean Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Kwang Dong Pharmaceutical

Market Cap: ₩210.9b

Operates as a human healthcare provider in South Korea.

JW Holdings

Market Cap: ₩210.4b

Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.

NatureCellLtd

Market Cap: ₩1.7t

Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.

ISU Abxis

Market Cap: ₩191.5b

A biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide.

JW Lifescience

Market Cap: ₩173.7b

Provides national infusion solutions in South Korea and internationally.

KOREA PHARMA

Market Cap: ₩154.9b

Produces pharmaceutical drugs.

Komipharm International

Market Cap: ₩354.8b

Manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally.

JW Pharmaceutical

Market Cap: ₩510.3b

Manufactures and sells medicines and medical supplies in Japan and internationally.

DongKook Pharmaceutical

Market Cap: ₩678.8b

Produces and sell pharmaceutical products in South Korea and internationally.

Boryung

Market Cap: ₩719.6b

Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.

Daihan PharmaceuticalLtd

Market Cap: ₩152.0b

Engages in the manufacture and sale of therapeutic drugs in South Korea.